Sunday 23 September 2018
Contact US    |    Archive
Channel News Asia
2 months ago

Zogenix s treatment for rare epilepsy meets advanced study goal

REUTERS: Zogenix Inc said on Thursday its drug to treat Dravet syndrome, a rare form of epilepsy, met the main goal of a late-stage trial. The study, the second late-stage trial of the drug, found that the treatment led to a reduction in reduction in mean monthly seizures, when compared with a ...

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Zogenix

 | 

treatment

 | 

for

 | 

rare

 | 

epilepsy

 | 

meets

 | 

advanced

 | 

study

 | 

goal

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Love, interrupted

- inquirer

Most Popular (a week)